Zhang CZ - Search Results

1

EFHD1, a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma.

Meng K, Hu Y, Wang D, Li Y, Shi F, Lu J, Wang Y, Cao Y, Zhang CZ, He QY. Meng K, et al. Among authors: zhang cz. Cancer Sci. 2023 May;114(5):2029-2040. doi: 10.1111/cas.15749. Epub 2023 Feb 26. Cancer Sci. 2023. PMID: 36747492 Free PMC article.

2

Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.

Zhang CZ, Pan Y, Cao Y, Lai PB, Liu L, Chen GG, Yun J. Zhang CZ, et al. PLoS One. 2012;7(6):e39870. doi: 10.1371/journal.pone.0039870. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761917 Free PMC article.

3

High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.

Cai MY, Luo RZ, Li YH, Dong P, Zhang ZL, Zhou FJ, Chen JW, Yun JP, Zhang CZ, Cao Y. Cai MY, et al. Among authors: zhang cz, zhang zl. Biochem Biophys Res Commun. 2012 Oct 5;426(4):636-42. doi: 10.1016/j.bbrc.2012.08.146. Epub 2012 Sep 11. Biochem Biophys Res Commun. 2012. PMID: 22982674

4

Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.

Zhang CZ, Liu L, Cai M, Pan Y, Fu J, Cao Y, Yun J. Zhang CZ, et al. PLoS One. 2012;7(12):e51703. doi: 10.1371/journal.pone.0051703. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23272146 Free PMC article.

5

Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.

Fu J, Qiu H, Cai M, Pan Y, Cao Y, Liu L, Yun J, Zhang CZ. Fu J, et al. Among authors: zhang cz. Cancer Sci. 2013 Apr;104(4):508-15. doi: 10.1111/cas.12100. Epub 2013 Feb 17. Cancer Sci. 2013. PMID: 23305207 Free PMC article.

6

miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.

Zhang CZ, Cao Y, Fu J, Yun JP, Zhang MF. Zhang CZ, et al. Among authors: zhang mf. Mol Oncol. 2016 Dec;10(10):1532-1541. doi: 10.1016/j.molonc.2016.09.001. Epub 2016 Sep 20. Mol Oncol. 2016. PMID: 27693040 Free PMC article.

7

Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.

Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL, Fu J, Zhang L, Wang H, Xie D, Yun JP. Lu SX, et al. Among authors: zhang cz, zhang l. Cancer Lett. 2017 Aug 28;402:71-80. doi: 10.1016/j.canlet.2017.05.018. Epub 2017 Jun 1. Cancer Lett. 2017. PMID: 28577975

8

CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma.

Zhang CZ, Chen SL, Wang CH, He YF, Yang X, Xie D, Yun JP. Zhang CZ, et al. Cancer Res. 2018 Jan 1;78(1):51-63. doi: 10.1158/0008-5472.CAN-17-0700. Epub 2017 Oct 24. Cancer Res. 2018. PMID: 29066512

9

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.

Chen SL, Zhang CZ, Liu LL, Lu SX, Pan YH, Wang CH, He YF, Lin CS, Yang X, Xie D, Yun JP. Chen SL, et al. Among authors: zhang cz. Cancer Res. 2019 Feb 1;79(3):534-545. doi: 10.1158/0008-5472.CAN-18-2357. Epub 2018 Dec 24. Cancer Res. 2019. PMID: 30584071

10

CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.

Jiang N, Niu G, Pan YH, Pan W, Zhang MF, Zhang CZ, Shen H. Jiang N, et al. Among authors: zhang cz, zhang mf. EBioMedicine. 2020 Mar;53:102692. doi: 10.1016/j.ebiom.2020.102692. Epub 2020 Feb 26. EBioMedicine. 2020. PMID: 32113161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters